Health Economics for Medical Devices

$3,495.00

Use this report to understand how health economics and outcomes research (HEOR) teams can best support Class II and Class III medical devices throughout their lifecycles — protecting them from reductions in reimbursement level and reinforcing price points. Benchmarks and best practices guide medical device firms to assemble a strong, reimbursementfocused HEOR group equipped to anticipate and fulfill payer requirements. HEOR groups’ activity, spending, compensation and outsourcing data enable device firms to prioritize tasks and maintain highly skilled, experienced health economics teams. This study also helps HEOR teams gain a better understanding of the competitive landscape and marketplace when making study decisions. Top executives’ insights, combined with cost and duration data, provide expert advice in choosing the right HEOR study — critical to best achieving reimbursement.

Download a benchmarking report summarySpeak to a pharmaceutical benchmarking expert

Report Details

Publication Date: Apr 2014
Pages: 63
Chapters: 3
Metrics: 400+
Charts/Graphics: 40+

Top Reasons to Buy This Health Economics for Medical Devices Report

Maximize HEOR Groups’ Impact: For many device companies, HEOR groups are becoming more prominent. In some cases, building a strong HEOR group means transitioning from a clinically oriented team to one focused on reimbursement. Aligning these groups under market access to distribute findings across internal and external stakeholders throughout a product’s lifecycle can be the key to success. Learn how to achieve group alignment, develop more experienced health economics groups and what activities should be performed by HEOR teams.

Explore Outsourcing to Meet Market Needs: Medical device companies increasingly use outsourcing to fill knowledge gaps as well as to meet market needs. This study reveals the importance of tailoring outsourcing activities to match payer requirements in terms of clinical trial data or market research. Through examining device companies’ outsourcing practices and approaches to balancing in-house activities and third-party vendors, our analysts were able to analyze and give key outsourcing recommendations. Specifically, this section of the report will help your team understand competition and alternative treatments when determining appropriate HEOR outsourcing spend.

Pinpoint the Most Cost-Effective HEOR Study: This report shows the costs and durations of different types of HEOR studies that medical device companies regularly conduct to best achieve product reimbursement. The best practices included in the study will demonstrate how device company executives get the most out of HEOR teams to drive optimal reimbursement strategy. It also covers the number of each type of study that surveyed companies conduct each year, from 2012 through 2014.  This data analysis examines the many different reasons — ranging from cost to marketplace drivers to payers — that cause companies to choose one HEOR study over another.

You may also be interested in CEIConnect: The Lifesciences Industry’s On-Demand Research Resource as well as our individual medical device research reports.

Excerpt from Health Economics for Medical Devices

Medical device companies in today’s austerity-driven marketplace encounter a
number of challenges. As these companies generally comprise a substantial portion of healthcare provider and hospital budgets, they are easy targets for cost-cutting measures. Device companies must understand each payer’s needs and be prepared to make extensive and evidence-based justifications for each product in their portfolio.

As a result of their product portfolio’s complexity and a different type of product lifecycle, medical device companies face challenges that are different from the conventional pharmaceutical industry. Companies need to be well prepared for payer demands in terms of improving payers’ understanding of these medical devices’ technical aspects.

Table of Contents

5              Executive Summary

17           Building a Robust Health Economics Foundation through Structure and Staffing

18           Structure Health Economics Teams for Excellence

26           Staff Health Economics Groups to Support a Range of Internal Functions

42           Embrace Health Economics Trends to Thrive in a Global Marketplace

44           Understanding Medical Device HEOR Spending and Outsourcing

45           Spending on Medical Device Health Economics-Related Activities

49           HEOR Compensation and Outsourcing

53           Selecting the Most Appropriate HEOR Study To Maintain Ideal Cost and Duration

Charts and Graphics

 5             Executive Summary

11           Figure E.1: Structure of HEOR Groups: All Medical Device Companies

12           Figure E.2: Function Overseeing HEOR Groups: All Medical Device Companies

14           Figure E.3: Percentage of Medical Device HEOR Groups Involved in Developing Innovative New Products, by Group Type

17           Building a Robust Health Economics Foundation through Structure and Staffing

18           Structure Health Economics Teams for Excellence

19           Figure 1.1: Structure of HEOR Groups: All Medical Device Companies

20           Figure 1.2: Structure of In-House HEOR Groups: All Medical Device Companies

21           Figure 1.3: Level of HEOR Head: All Medical Device Companies

23           Figure 1.4: Function Overseeing HEOR Groups: All Medical Device Companies

24           Figure 1.5: Medical Device HEOR Group Structure: Company A

26           Staff Health Economics Groups to Support a Range of Internal Functions

27           Figure 1.6: Number of FTEs Dedicated to Medical Device HEOR Functions, by Position: Global Groups

28           Figure 1.7: Number of FTEs Dedicated to Medical Device HEOR Functions, by Position: Country-Level Groups

30           Figure 1.8: Percentage of Medical Device HEOR Groups Involved in Specific Activities: Global Level

32           Figure 1.9: Percentage of Medical Device HEOR Groups Involved in Specific Activities: Country Level

34           Figure 1.10: Percentage of Time Spent on Specific Activities: Global Medical Device HEOR Groups

36           Figure 1.11: Percentage of Time Spent on Specific Activities: Country-Level Medical Device HEOR Groups

37           Figure 1.12: Percentage of HEOR Groups Involved in Developing Innovative New Products, by Phase: All Medical Device Companies

38           Figure 1.13: Percentage of Medical Device HEOR Groups Involved in Developing Innovative New Products, by Group Type

39           Figure 1.14: Percentage of Companies Using Patient-Reported Outcomes (PROs): All Medical Device Companies

40           Figure 1.15: Percentage of Companies Outsourcing Patient-Reported Outcomes (PROs) Activities: All Medical Device Companies

41           Figure 1.16: Reliability of Patient-Reported Outcomes (PROs): All Medical Device Companies

42           Embrace Health Economics Trends to Thrive in a Global Marketplace

43           Figure 1.17: Level of Impact Associated with Medical Device HEOR Trends

44           Understanding Medical Device HEOR Spending and Outsourcing

45           Spending on Medical Device Health Economics-Related Activities

46           Figure 2.1: Annual HEOR Spending for Class II Medical Devices, by Company

46           Figure 2.2: Annual HEOR Spending for Class III Medical Devices, by Company

47           Figure 2.3: Percentage of Medical Device HEOR Spending, by Category

48           Figure 2.4: Percentage of Medical Device HEOR Spending, by Activity

49           HEOR Compensation and Outsourcing

49           Figure 2.5: Annual Compensation for HEOR-Related Positions at Medical Device Companies: Base Salary

50           Figure 2.6: Annual Compensation for HEOR-Related Positions at Medical Device Companies: Average Bonus

52           Figure 2.7: Percentage of HEOR Budget Outsourced Annually, by Company

53           Selecting the Most Appropriate HEOR Study to Maintain Ideal Cost and Duration

55           Figure 3.1: Number of Studies Conducted by Global Medical Device HEOR Teams, by Company: Cost-Effectiveness Model

56           Figure 3.2: Number of Studies Conducted by Global Medical Device HEOR Teams, by Company: Cost-Effectiveness with Budget Impact Model

56           Figure 3.3: Number of Studies Conducted by Global Medical Device HEOR Teams, by Company: Budget Impact Model (Stand-Alone)

57           Figure 3.4: Number of Studies Conducted by Global Medical Device HEOR Teams, by Company: Pricing Threshold Model

57           Figure 3.5: Number of Studies Conducted by Global Medical Device HEOR Teams, by Company: All Other Studies

58           Figure 3.6: Number of Studies Conducted by Country-Level Medical Device HEOR Teams, by Company: All Models

59           Figure 3.7: Cost of Studies Conducted by Medical Device HEOR Teams, by Study Type: All Companies

60           Figure 3.8: Cost of Studies Conducted by Medical Device HEOR Teams, by Company: Cost Effectiveness Model

61           Figure 3.9: Cost of Studies Conducted by Medical Device HEOR Teams, by Company: Cost Effectiveness with Budget Impact Model

61           Figure 3.10: Cost of Studies Conducted by Medical Device HEOR Teams, by Company: Budget Impact Model (Stand-Alone)

62           Figure 3.11: Cost of Studies Conducted by Medical Device HEOR Teams, by Company: Pricing Threshold Model

62           Figure 3.12: Cost of Studies Conducted by Medical Device HEOR Teams, by Company: All Other Studies

63           Figure 3.13: Duration of Studies Conducted by Medical Device HEOR Teams, by Company: All Studies